CD86 and neoplasm: Interestingly, CD68+CD163+ cells demonstrated high expression of CD14, CD16, ITGAX (CD11c), CD86 and CD45 in all three tumour types, supporting an origin from blood intermediate monocytes58 (Supplementary Figure S6, lower panel).